These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 11896503)

  • 101. Prevalence of primary aldosteronism without hypertension in the general population: Results in Shika study.
    Karashima S; Kometani M; Tsujiguchi H; Asakura H; Nakano S; Usukura M; Mori S; Ohe M; Sawamura T; Okuda R; Hara A; Takamura T; Yamagishi M; Nakamura H; Takeda Y; Yoneda T
    Clin Exp Hypertens; 2018; 40(2):118-125. PubMed ID: 28723305
    [TBL] [Abstract][Full Text] [Related]  

  • 102. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
    Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
    Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.
    Morimoto R; Ono Y; Tezuka Y; Kudo M; Yamamoto S; Arai T; Gomez-Sanchez CE; Sasano H; Ito S; Satoh F
    Hypertension; 2017 Aug; 70(2):334-341. PubMed ID: 28652474
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Incidence of primary hyperaldosteronism in hospitalized patients with hypertension].
    Lazurova I; Schwartz P; Trejbal D; Zachar M; Bober J; Sokol L; Wagnerova H; Trejbalova L; Valansky L
    Bratisl Lek Listy; 1999 Apr; 100(4):200-3. PubMed ID: 10914143
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment.
    Armanini D; Sabbadin C; Boscaro M
    J Endocrinol Invest; 2021 Sep; 44(9):2009-2010. PubMed ID: 33454931
    [No Abstract]   [Full Text] [Related]  

  • 106. Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism.
    Schilbach K; Junnila RK; Bidlingmaier M
    Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):84-92. PubMed ID: 30165708
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [Renin-angiotensin-aldosterone function tests].
    Haruyama K; Fukuchi S
    Nihon Rinsho; 1982; 40(9):1997-2002. PubMed ID: 6296488
    [No Abstract]   [Full Text] [Related]  

  • 108. Spectrum of renin angiotensin aldosterone system disorders in young hypertensives.
    Gilani M; Asif N; Akram A; Gilani M; Ijaz A; Malik SS
    J Pak Med Assoc; 2018 Aug; 68(8):1179-1182. PubMed ID: 30108382
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Some considerations about evolution of idiopathic primary aldosteronism.
    Armanini D; Fiore C
    J Endocrinol Invest; 2009 Jul; 32(7):623-5. PubMed ID: 19893360
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study.
    Parthasarathy HK; Alhashmi K; McMahon AD; Struthers AD; Connell JM; McInnes GT; Ford I; MacDonald TM
    BMC Cardiovasc Disord; 2007 May; 7():14. PubMed ID: 17490489
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Aldo is back: recent advances and unresolved controversies in hyperaldosteronism.
    Auchus RJ
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):153-8. PubMed ID: 12589175
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Primary aldosteronism with HIV infection: important considerations when using the aldosterone:renin ratio to screen this unique population.
    Fradley M; Liu J; Atta MG
    Am J Ther; 2005; 12(4):368-74. PubMed ID: 16041202
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses.
    Tzanela M; Effraimidis G; Vassiliadi D; Szabo A; Gavalas N; Valatsou A; Botoula E; Thalassinos NC
    Endocrine; 2007 Oct; 32(2):136-42. PubMed ID: 18040893
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.
    Vaidya A; Carey RM
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3771-83. PubMed ID: 32865201
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism.
    Burrello J; Buffolo F; Domenig O; Tetti M; Pecori A; Monticone S; Poglitsch M; Mulatero P
    Hypertension; 2020 Jan; 75(1):163-172. PubMed ID: 31760886
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Primary aldosteronism in general practice.
    Chan NN; Isaacs AJ
    Lancet; 1999 Mar; 353(9157):1013; author reply 1014. PubMed ID: 10459937
    [No Abstract]   [Full Text] [Related]  

  • 117. [Occurrence and diagnosis of primary aldosteronism and its therapy].
    Nishikawa T; Saito J; Soyama A; Ito H; Omura M
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):208-12. PubMed ID: 12652723
    [No Abstract]   [Full Text] [Related]  

  • 118. Primary aldosteronism: what consensus for the diagnosis.
    Cicala MV; Mantero F
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):915-21. PubMed ID: 21115160
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism.
    McKenna TJ; Sequeira SJ; Heffernan A; Chambers J; Cunningham S
    J Clin Endocrinol Metab; 1991 Nov; 73(5):952-7. PubMed ID: 1939533
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The influence of a heparin-like compound on hypertension, electrolytes and aldosterone in man.
    Abbott EC; Gornall AG; Sutherland DJ; Laidlaw JC; Stiefel M
    Can Med Assoc J; 1966 May; 94(22):1155-64. PubMed ID: 4222823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.